Abstract
A series of new of 2-furano-4(3H)-quinazolinone derivatives 5 (a-t) were synthesized. The compounds were characterized by their IR, 1H NMR, 13C NMR, and Mass spectral data. The antimicrobial activity of newly anthranilic acid-based compounds against various bacteria; S. aureus, Salmonella enterica, Vibrio cholerae, Bacillus subtilis, Proteus mirabili, Escherichia coli V517, Mycobacterium smegmatics, Pseudomonas aeruginosa and fungi; C. albicans, were evaluated with ampicillin and amphotericin B as standards. All compounds were also evaluated for antibacterial activity against R. solanacearum along with Kocide 3000 as a commercialized reference. Compounds 5d, 5g, 5j, 5l, 5q, 5r, 5s, and 5t exhibited good potential as antimicrobial.
Keywords: Synthesis, Quinazolinone, Diamide (open quinazoline ring), Antimicrobial activity
Letters in Drug Design & Discovery
Title:Certain 2-Furano-4(3H)-Quinazolinone Analogs: Synthesis, Characterization and Pharmacological Evaluation
Volume: 10 Issue: 4
Author(s): Varun Bhardwaj, Poonam Sharma, Malleshappa N. Noolvi, Harun M. Patel, Sumit Bansal, Sandeep Lohan and Gaurav Badola
Affiliation:
Keywords: Synthesis, Quinazolinone, Diamide (open quinazoline ring), Antimicrobial activity
Abstract: A series of new of 2-furano-4(3H)-quinazolinone derivatives 5 (a-t) were synthesized. The compounds were characterized by their IR, 1H NMR, 13C NMR, and Mass spectral data. The antimicrobial activity of newly anthranilic acid-based compounds against various bacteria; S. aureus, Salmonella enterica, Vibrio cholerae, Bacillus subtilis, Proteus mirabili, Escherichia coli V517, Mycobacterium smegmatics, Pseudomonas aeruginosa and fungi; C. albicans, were evaluated with ampicillin and amphotericin B as standards. All compounds were also evaluated for antibacterial activity against R. solanacearum along with Kocide 3000 as a commercialized reference. Compounds 5d, 5g, 5j, 5l, 5q, 5r, 5s, and 5t exhibited good potential as antimicrobial.
Export Options
About this article
Cite this article as:
Bhardwaj Varun, Sharma Poonam, N. Noolvi Malleshappa, M. Patel Harun, Bansal Sumit, Lohan Sandeep and Badola Gaurav, Certain 2-Furano-4(3H)-Quinazolinone Analogs: Synthesis, Characterization and Pharmacological Evaluation, Letters in Drug Design & Discovery 2013; 10 (4) . https://dx.doi.org/10.2174/1570180811310040010
DOI https://dx.doi.org/10.2174/1570180811310040010 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cancer and Virus Leads by HTS, Chemical Design and SEA Data Mining
Current Topics in Medicinal Chemistry Targeting of Metabotropic Glutamate Receptors for the Treatment of Schizophrenia
Current Pharmaceutical Design Regulation of RhoA Activity by Adhesion Molecules and Mechanotransduction
Current Molecular Medicine Pharmacotherapy for Hoarding Disorder: How did the Picture Change since its Excision from OCD?
Current Neuropharmacology Immunogenetic Mechanisms Leading to Thyroid Autoimmunity: Recent Advances in Identifying Susceptibility Genes and Regions
Current Genomics n-3 Fatty Acids: Role in Neurogenesis and Neuroplasticity
Current Medicinal Chemistry Naltrexone for the Treatment of Alcoholism: Clinical Findings, Mechanisms of Action, and Pharmacogenetics
CNS & Neurological Disorders - Drug Targets Enriching One’s Environment in the Face of Cognitive and Functional Loss
Current Neurovascular Research Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain
CNS & Neurological Disorders - Drug Targets Nanoparticle Based Gene Therapy Approach: A Pioneering Rebellion in the Management of Psychiatric Disorders
Current Gene Therapy Role of Presynaptic Glutamate Receptors in Pain Transmission at the Spinal Cord Level
Current Neuropharmacology Common and Distinct Interactions of Chemical Inhibitors with Cytochrome P450 CYP1A2, CYP2A6 and CYP2B6 Enzymes
Drug Metabolism Letters Drugs and Aggression
Recent Patents on CNS Drug Discovery (Discontinued) Inflammation and Age-Related Iron Accumulation in F344 Rats
Current Aging Science Co-Morbidity and Self Medication in Schizophrenia: Involvement of Endogenous Morphine Signaling Mechanisms
Current Drug Targets Neuropeptides in Alzheimer’s Disease: From Pathophysiological Mechanisms to Therapeutic Opportunities
Current Alzheimer Research Treating Cancer in Older and Oldest Old Patients
Current Pharmaceutical Design Patent Selections:
Current Biomarkers (Discontinued) The Role of Cytokine Network in the Pathophysiology of Schizophrenia
Current Psychiatry Reviews Trimethylamine: Metabolic, Pharmacokinetic and Safety Aspects
Current Drug Metabolism